Avandia To Be Removed from Tennessee Retail Pharmacies

By | Dangerous & Defective Drugs

Recognizing the heart risks Avandia poses to those who use it, the Food and Drug Administration announced new rules in May to pull the diabetes drug from the shelves of retail pharmacies throughout Tennessee and the rest of the U.S. Although the new rules don’t go into effect until November, many pharmacies have already stopped dispensing the controversial drug. Linked to severe cardiovascular events, including heart attack, congestive heart failure, stroke and liver problems, the FDA has determined that in the majority of cases, the risks of Avandia far outweigh its benefits for those living with Type 2 diabetes. The FDA’s…

Read More

FDA Warns Against Avandia

By | Dangerous & Defective Drugs

Avandia, a popular but controversial diabetes medication, is facing new government scrutiny, putting manufacturer GlaxoSmithKline at risk of potentially costly new lawsuits. In February, the New York Times obtained a confidential Food and Drug Administration report that linked more than 300 deaths to Avandia within a three-month period. The report recommended pulling the drug from the market. The new FDA data follows a U.S. Senate Finance Committee report released in February. The senate report alleges that GSK knew of the health risks prior to 2007 but concealed them. Avandia could quite possibly be a dangerous and defective drug. Avandia first hit…

Read More